O-186 Mutations in EGFR, HER2, KRAS and BRAF in NSCLC: Prevalences and correlations with clinical outcomes in patients treated with carboplatin and paclitaxel with or without erlotinib
Year: 2005
Type: conference-abstract
Source: Lung Cancer
Authors: D. Eberhard, B. Johnson, A. Goddard, R. Herbst, P. Janne, D. Johnson, P. Klein, M. Ostland, S. Seshagiri, K. Hillan
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1977781452
